admin

Have you ever wondered what rules Warren Buffett might use to analyze potential stock picks. In episode three, the Stig and Preston discuss Buffett’s 4 rules to selecting a successful stock pick. You won’t want to miss this important discussion! IN THIS EPISODE, YOU’LL LEARN: – Vigilant leadership – Long term prospects – Stable and
0 Comments
EV charging leader ChargePoint (NYSE:CHPT) has hit a rough patch recently. CHPT stock dropped 29% over the past month amid worries surrounding a lack of charging infrastructure spend in Biden’s new infrastructure bill. Also present are concerns that EV spending will take a backseat in the event that Covid-19 becomes a headline problem again. Source: YuniqueB
0 Comments
Growth has clearly been the winning investment strategy over the past decade. Buying shares of well-managed businesses in industries with above-average growth has proven capable of superior portfolio performance. Therefore today, we’ll discuss seven growth stocks that could be appropriate for a range of InvestorPlace.com readers. Most growth stock have high valuation metrics, such above
0 Comments
Income investors are always searching for high yields, which are hard to find with today’s historically low interest rates and record-high stock prices. But investors should not sacrifice dividend safety in favor of higher yields. This is why high-quality dividend stocks like the Dividend Aristocrats are so valuable. The Dividend Aristocrats are a select group
0 Comments
In any other circumstance, Opendoor Technologies (NASDAQ:OPEN) stock may have been a no-brainer investment. Source: PREMIO STOCK/Shutterstock.com As you probably know, owning real estate is the epitome of the American Dream — but the paperwork to seal the deal is a veritable nightmare. Opendoor’s digitalization of the buying and selling process is the answer we’ve
0 Comments
Small biotech companies such as Denmark’s Orphazyme (NASDAQ:ORPH) usually have one major product, which pushes them into the spotlight. For ORPH stock, that one product is Arimoclomol. Source: Iryna Imago / Shutterstock.com Arimoclomol is a drug that could treat the rare progressive genetic disorder called Niemann-Pick Disease Type C (NPC). Investors looking for a breakthrough
0 Comments